GlassScriptPhysician profile
Rashid H Khan
NPI 1437211786
$45,094.35
in general payments reported to CMS, 2019-2025
28 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $2,827 · 2021: $1,771 · 2022: $13K · 2023: $4,498 · 2024: $3,662 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,375 · Food and Beverage: $3,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,375.00 |
| Food and Beverage | $3,427.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $34,363.00 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $5,970.87 | 2019 | |
| Gilead Sciences, INC. | $1,538.84 | 2019-2020 | |
| Madrigal Pharmaceuticals | $1,015.05 | 2024-2025 | Rezdiffra, Resmetirom |
| Lilly USA, LLC | $297.31 | 2024-2025 | Omvoh |
| E.R. Squibb & Sons, L.L.C. | $227.03 | 2024 | Zeposia |
| Janssen Biotech, INC. | $200.67 | 2024-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.24 | 2019-2025 | Xifaxan |
| Genzyme Corporation | $170.74 | 2022-2023 | |
| Fujifilm Healthcare Americas Corporation | $167.41 | 2021 | |
| Phathom Pharmaceuticals, INC. | $160.33 | 2024-2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $159.31 | 2019-2025 | Ocaliva |
| Mirum Pharmaceuticals, INC. | $150.00 | 2025 | Livmarli |
| Takeda Pharmaceuticals U.S.A., INC. | $108.83 | 2019-2024 | Entyvio |
| Shionogi INC | $61.99 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $57.72 | 2024-2025 | Dupixent |
| Celgene Corporation | $37.52 | 2024 | Zeposia |
| Braintree Laboratories, INC. | $35.72 | 2021 | |
| Medtronic, INC. | $29.12 | 2021-2023 | Gi Genius |
| Genentech USA, INC. | $25.25 | 2025 | Venclexta |
| Ironwood Pharmaceuticals, INC | $22.99 | 2023 | Linzess |
| Ipsen Biopharmaceuticals, INC | $19.26 | 2025 | Iqirvo |
| Novo Nordisk INC | $18.91 | 2021 | |
| Shield Therapeutics INC | $18.08 | 2024 | |
| Aimmune Therapeutics, INC. | $17.36 | 2024 | |
| Redhill Biopharma INC. | $15.33 | 2021 | |
| Ardelyx, INC. | $14.71 | 2024 | Ibsrela |
| Antares Pharma, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashid Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.